Ipamorelin – Selective Growth Hormone Secretagogue for Research
Ipamorelin is an advanced synthetic pentapeptide developed for professional laboratory research involving growth hormone secretagogue receptor activity, pituitary signalling and endocrine pathway analysis.
Its compact five-amino-acid structure and selective research profile make Ipamorelin particularly relevant for studies examining ghrelin-receptor pharmacology, growth hormone release mechanisms, receptor activation and peptide structure–activity relationships.
Supplied as a premium lyophilised research material, Ipamorelin offers laboratories a convenient and clearly defined compound for advanced analytical, biochemical and comparative peptide research.
Key Product Features
- Synthetic pentapeptide research compound
- Selective growth hormone secretagogue
- Relevant for GHS-R1a and ghrelin-receptor research
- Compact five-amino-acid structure
- Suitable for pituitary-signalling studies
- Useful for endocrine pathway research
- Relevant for receptor-binding analysis
- Supplied as a lyophilised research material
- Clear batch-specific product information
- Secure and discreet packaging
- Fast and trackable European delivery
What Is Ipamorelin?
Ipamorelin is a synthetic growth hormone-releasing pentapeptide belonging to the growth hormone secretagogue family.
Its peptide sequence is:
Aib–His–D-2-Nal–D-Phe–Lys-NH₂
The sequence contains modified and non-standard amino-acid components that contribute to its distinctive receptor activity, molecular stability and analytical profile.
Ipamorelin was developed during research into compounds capable of interacting with the growth hormone secretagogue receptor while offering a more selective endocrine research profile than several earlier growth hormone-releasing peptides.
Growth Hormone Secretagogue Receptor Research
Ipamorelin is primarily studied in relation to the growth hormone secretagogue receptor type 1a, commonly abbreviated as GHS-R1a.
GHS-R1a is also known as the ghrelin receptor and belongs to the G-protein-coupled receptor family. It is expressed in the pituitary, hypothalamus and several peripheral tissues.
Potential research areas include:
- GHS-R1a receptor binding
- Ghrelin-receptor activation
- Ligand–receptor interactions
- G-protein-coupled receptor signalling
- Intracellular calcium mobilisation
- Pituitary-cell responses
- Concentration–response relationships
- Receptor sensitivity
- Receptor internalisation
- Comparative agonist pharmacology
The exact concentrations, controls and analytical procedures should be determined by the qualified laboratory conducting the research.
Selective Research Profile
Ipamorelin was originally characterised as a selective growth hormone secretagogue.
Early experimental research examined its ability to stimulate growth hormone-related pathways while producing a more selective response than several older GHRP compounds in the tested models.
This makes Ipamorelin useful for comparative laboratory research involving:
- Selective receptor activation
- Growth hormone release pathways
- Endocrine response profiles
- Pituitary hormone signalling
- Receptor specificity
- Comparative secretagogue research
- Structure–activity relationships
- Modified peptide pharmacology
Selectivity can depend on the experimental system, concentration and analytical method used.
Pituitary Signalling Research
The anterior pituitary contains specialised cells involved in growth hormone synthesis and release.
Ipamorelin may be used in laboratory studies examining:
- Somatotroph-cell activity
- Pituitary receptor signalling
- Growth hormone secretion models
- Intracellular calcium signalling
- Endocrine pulse patterns
- Hormone-release kinetics
- Pituitary-cell responsiveness
- Receptor-mediated exocytosis
- Comparative pituitary assays
- Endocrine feedback mechanisms
These research applications describe experimental pathways and do not represent therapeutic claims.
Ghrelin-Pathway Research
Ghrelin is the naturally occurring ligand for GHS-R1a. The ghrelin system is studied in connection with endocrine communication, gastrointestinal signalling, appetite-related pathways and energy homeostasis.
As a synthetic GHS-R1a agonist, Ipamorelin may be relevant for research involving:
- Ghrelin-receptor pharmacology
- Endocrine signalling
- Hypothalamic–pituitary communication
- Gastrointestinal receptor expression
- Cellular calcium responses
- Metabolic signalling
- Receptor selectivity
- Ligand comparison
- Ghrelin-mimetic compounds
- GPCR pathway analysis
Ipamorelin is structurally different from natural ghrelin and should be treated as a separate synthetic research compound.
Ipamorelin Versus GHRH Analogues
Ipamorelin should not be confused with growth hormone-releasing hormone analogues such as CJC-1295 or Modified GRF (1–29).
These compounds act through different receptor pathways.
| Characteristic |
Ipamorelin |
| Compound type |
Growth hormone secretagogue |
| Primary receptor |
GHS-R1a |
| Alternative receptor name |
Ghrelin receptor |
| Peptide length |
Five amino-acid components |
| Main research area |
Ghrelin-receptor and pituitary signalling |
| Compound class |
Synthetic pentapeptide |
Researchers may compare Ipamorelin with GHRH analogues to investigate how separate upstream receptor systems influence pituitary signalling.
Peptide Structure Research
The compact structure of Ipamorelin makes it useful for research involving synthetic peptide design.
Potential applications include:
- Pentapeptide characterisation
- Modified amino-acid research
- Receptor-binding optimisation
- Structure–activity relationships
- Peptide stability
- Enzymatic degradation
- Synthetic peptide chemistry
- Comparative sequence analysis
- Molecular modelling
- Peptide–receptor interactions
The inclusion of modified amino-acid components distinguishes Ipamorelin from naturally occurring peptide sequences.
Potential Research Applications
Ipamorelin may be relevant for controlled scientific research involving:
- Growth hormone secretagogue receptors
- GHS-R1a activation
- Ghrelin-receptor pharmacology
- Pituitary-cell signalling
- Growth hormone release models
- Endocrine feedback systems
- Intracellular calcium signalling
- GPCR pharmacology
- Receptor selectivity
- Peptide structure–activity relationships
- Comparative secretagogue research
- Synthetic pentapeptide analysis
- Analytical peptide characterisation
- Stability and degradation studies
- Chromatographic analysis
- Mass-spectrometry analysis
Analytical Research
Ipamorelin may be suitable for analytical laboratory work involving:
- High-performance liquid chromatography
- Liquid chromatography–mass spectrometry
- Peptide identity confirmation
- Purity assessment
- Stability testing
- Degradation profiling
- Solubility analysis
- Reference-material comparison
- Formulation compatibility
- Analytical method development
- Comparative peptide analysis
Researchers should select solvents and analytical conditions that have been validated specifically for Ipamorelin.
Product Specifications
| Product characteristic |
Information |
| Product name |
Ipamorelin |
| Product category |
Synthetic research peptide |
| Compound class |
Growth hormone secretagogue |
| Peptide type |
Pentapeptide |
| Sequence |
Aib–His–D-2-Nal–D-Phe–Lys-NH₂ |
| Primary research target |
GHS-R1a |
| Alternative receptor name |
Ghrelin receptor |
| Primary research area |
Pituitary and endocrine signalling |
| Form |
Lyophilised research material |
| Presentation |
Securely sealed research vial |
| Documentation |
Batch-specific analytical information |
| Packaging |
Secure and discreet packaging |
| Intended application |
Scientific, analytical and laboratory research |
Lyophilised Research Format
Ipamorelin is supplied as a lyophilised research material in a securely sealed vial.
Lyophilisation removes moisture and helps support product stability during controlled storage and transport. Minor variations in physical appearance may occur due to production conditions, quantity and residual moisture.
Product identity, purity and analytical quality should be confirmed using the documentation associated with the applicable batch rather than physical appearance alone.
Quality and Product Transparency
Peptides Divas focuses on clear product information, careful handling and batch-level traceability.
Available analytical documentation may include:
- Product identification
- Peptide sequence
- Batch or lot number
- Reported purity
- HPLC analysis
- Mass-spectrometry data
- Testing information
- Product appearance
- Storage recommendations
This provides researchers with clear and traceable product information for the applicable batch.
Storage Information
Store Ipamorelin in its original sealed packaging according to the conditions stated on the product label and applicable batch documentation.
Protect the research material from:
- Direct sunlight
- Excessive heat
- Moisture
- Contamination
- Damaged packaging
- Repeated temperature fluctuations
- Unnecessary exposure to air
The receiving laboratory is responsible for establishing suitable preparation, handling and storage procedures for its specific research protocol.
Why Choose Ipamorelin?
Ipamorelin provides a clearly defined and selective research profile for laboratories examining ghrelin-receptor and pituitary signalling.
Key research advantages include:
- Compact synthetic pentapeptide structure
- Direct relevance to GHS-R1a research
- Suitable for selective secretagogue studies
- Useful for pituitary-cell models
- Relevant for endocrine pathway research
- Valuable for GPCR pharmacology
- Suitable for comparative peptide analysis
- Convenient lyophilised presentation
- Clear batch-specific product information
Why Order from Peptides Divas?
Peptides Divas combines carefully selected research materials with fast, reliable and professional service.
Customers benefit from:
- Clearly displayed product specifications
- Batch-specific analytical information
- Fast order processing
- Secure and discreet packaging
- Trackable shipping options
- Careful vial protection
- Responsive customer support
- Reliable European delivery
Choose Ipamorelin from Peptides Divas for advanced laboratory research involving GHS-R1a activation, ghrelin-receptor pharmacology, pituitary signalling and synthetic peptide analysis.
For laboratory research use only. Not intended for human or veterinary use.
